Literature DB >> 8586123

Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media.

T Schaberg1, B Reichert, T Schülin, H Lode, H Mauch.   

Abstract

Radiometric methods for M. tuberculosis drug susceptibility testing yield much faster results than standard techniques; however, these methods require sophisticated equipment and are expensive. We investigated a rapid drug susceptibility testing method for isoniazid, rifampin, ethambutol, streptomycin and pyrazinamide in specimens from 197 patients with pulmonary tuberculosis using a simplified agar-dilution method. Middlebrook 7H11 agar solid medium and microcolony detection were used to test sputum from 64 smear-positive, and from 70 culture-positive but smear-negative patients. Culture-positive material from bronchoscopy, surgical biopsy, pleural fluid or gastric fluid of 63 patients was tested. In 64 smear-positive patients, the median time for final susceptibility results was 11 days (95% confidence interval (95% CI) 10-12 days) compared to 62 days (95% CI 56-66 days) with the standard method. In 133 smear-negative patients, results were available after a median of 35 days (95% CI 32-40 days) in contrast to 72 days (95% CI 62-83 days) with the standard method, regardless of whether or not sputum or other materials were used for primary culture. The rapid method detected all cases of single-drug resistance (n = 20) and multidrug resistance (n = 14) within 13 days (95% CI 9-17 days) in smear-positive patients (n = 8), or within 38 days (95% CI 35-48 days) in smear-negative patients (n = 26). Only one discrepancy was encountered in 985 resistance tests. Moreover, contamination was not observed. Our rapid susceptibility testing method for M. tuberculosis on Middlebrook 7H11 agar is fast, practical and inexpensive. It provides an alternative when more sophisticated techniques are not available or affordable.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586123     DOI: 10.1183/09031936.95.08101688

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.

Authors:  Md A Gazi; Md R Islam; Mohammad G Kibria; Z Mahmud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-06       Impact factor: 3.267

2.  Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system.

Authors:  Won-Jung Koh; Yousang Ko; Chang-Ki Kim; Kyung Sun Park; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

3.  The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results.

Authors:  Joon-Sung Joh; Chang Hoon Lee; Ji Eun Lee; Young-Kil Park; Gill-Han Bai; Eui-Chong Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

4.  Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications.

Authors:  Yong Suk Jo; Ju-Hee Park; Jung Kyu Lee; Eun Young Heo; Hee Soon Chung; Deog Kyeom Kim
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

5.  Performance of the BacT Alert 3D System Versus Solid Media for Recovery and Drug Susceptibility Testing of Mycobacterium tuberculosis in a Tertiary Hospital in Korea.

Authors:  Seoung-Cheol Kim; Bo-Young Jeon; Jin-Sook Kim; In Hwan Choi; Jiro Kim; Jeongim Woo; Soojin Kim; Hyeong Woo Lee; Monoldorova Sezim; Sang-Nae Cho
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

6.  Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi.

Authors:  Annie Zhang; Enoch Jumbe; Robert Krysiak; Sabeen Sidiki; Holden V Kelley; Elly K Chemey; Chancy Kamba; Victor Mwapasa; Juan I García; Alison Norris; Xueliang J Pan; Carlton Evans; Shu-Hua Wang; Jesse J Kwiek; Jordi B Torrelles
Journal:  Afr J Lab Med       Date:  2018-06-04

7.  Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.

Authors:  Paola M V Rancoita; Federica Cugnata; Ana Luíza Gibertoni Cruz; Philip W Fowler; Daniela M Cirillo; Emanuele Borroni; Sarah J Hoosdally; Timothy M Walker; Clara Grazian; Timothy J Davies; Timothy E A Peto; Derrick W Crook
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

8.  Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.

Authors:  Biruk Mekonnen; Adane Mihret; Muluwork Getahun; Tsegaye Hailu; Sabeen Sidiki; Holden V Kelley; Julia M Scordo; W Garrett Hunt; Xueliang Pan; Joan-Miquel Balada-Llasat; Wondwossen Gebreyes; Carlton A Evans; Abraham Aseffa; Jordi B Torrelles; Shu-Hua Wang; Tamrat Abebe
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

9.  Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates.

Authors:  Nicolas Schönfeld; Thorsten Bergmann; Silvan Vesenbeckh; Harald Mauch; Gudrun Bettermann; Torsten T Bauer; Holger Rüssmann
Journal:  Lung India       Date:  2012-10

10.  Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction.

Authors:  Yong Suk Jo; Yee Hyung Kim; Jung Yeon Lee; Kyungjoo Kim; Ki-Suck Jung; Kwang Ha Yoo; Chin Kook Rhee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.